No abstract available
Publication types
-
Letter
-
Clinical Trial, Phase II
MeSH terms
-
Adult
-
Aged
-
Drug Resistance, Neoplasm
-
Female
-
Histone Deacetylase Inhibitors / administration & dosage
-
Histone Deacetylase Inhibitors / adverse effects
-
Histone Deacetylase Inhibitors / therapeutic use
-
Humans
-
Lymphoma, T-Cell, Peripheral* / drug therapy
-
Lymphoma, T-Cell, Peripheral* / mortality
-
Male
-
Middle Aged
-
Neoplasm Recurrence, Local / drug therapy
-
Neoplasm Recurrence, Local / pathology
-
Recurrence
-
Treatment Outcome
Substances
-
Histone Deacetylase Inhibitors